Clinical Trial Update: TheraSphere for the Treatment of Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TheraSphere in treating liver metastases has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases
• Neuroendocrine Carcinoma

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Colorectal Cancer, Carcinoma, Neuroendocrine | Phase 2 | Status: COMPLETED | Results posted: 2014-05-23